[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100440760":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":12,"centralContacts":27,"locations":37,"responsibleParty":53,"collaborators":56,"id":60,"slug":61,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":64,"acronym":12,"eligibilityCriteria":65,"healthyVolunteers":62,"sex":66,"minAge":67,"maxAge":12,"enrollmentInfo":68,"targetDuration":12,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":78,"overallStatus":39,"whyStopped":12,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"Medical University of South Carolina","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment as Usual","NO_INTERVENTION","Treatment as Usual (TAU) participants will follow traditional clinic pathways for receiving tobacco treatment in the Medical University of South Carolina Health Infectious Disease outpatient clinic. All patients randomized to TAU will have the opportunity to access smoking cessation pharmacotherapy from the Infectious Disease clinical pharmacist.",null,{"label":14,"type":15,"description":16,"interventionNames":17},"ProMOTE","EXPERIMENTAL","In the PrOMOTE group, the participants will be contacted by the clinical pharmacist on the tobacco treatment staff three times for medication prescriptions and refills. They will also receive brief counseling and motivational interviewing by the clinical pharmacist.",[18],"Behavioral: PrOMOTE",[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"BEHAVIORAL","PrOMOTE","This is an opt-out, proactive approach to tobacco treatment by a clinical pharmacy specialist. The pharmacist will call patients and offer an individualized pharmacotherapy prescription. The patient must opt-out for it not to be sent to their pharmacy. The patient will also receive brief motivational interviewing and behavioral counseling from the pharmacist.",[14],[26],"Proactive Outreach with Medication Opt-out for Tobacco Treatment Engagement",[28,33],{"name":29,"role":30,"phone":31,"phoneExt":12,"email":32},"Chloe Morone","CONTACT","843-637-0734","morone@musc.edu",{"name":34,"role":30,"phone":35,"phoneExt":12,"email":36},"Alana Rojewski","8438761593","rojewski@musc.edu",[38],{"facility":5,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"RECRUITING","Charleston","South Carolina","29425","United States","US",{"type":46,"coordinates":47},"Point",[48,49],-79.93275,32.77632,{"lat":49,"lon":48},[52],{"name":29,"role":30,"phone":31,"phoneExt":12,"email":12},{"type":54,"investigatorFullName":34,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"PRINCIPAL_INVESTIGATOR","Assistant Professor",[57],{"name":58,"class":59},"National Cancer Institute (NCI)","NIH","100440760","optimizing-tobacco-treatment-delivery-for-people-living-with-hiv-100440760",false,"NCT05019495","Optimizing Tobacco Treatment Delivery for People Living With HIV","Inclusion Criteria:\n\n* Age 21 and older\n* Current diagnosis of HIV\n* Current smoker (defined as self-report of current smoking)\n* Willing to be randomized\n* English speaking\n\nExclusion Criteria:\n\n* Currently taking part in any other tobacco treatment program or using cessation medication (i.e., taking nicotine replacement therapy or other cessation medications, enrolled in the Quitline, or in another study)\n* Currently imprisoned\n* Pregnant women\n* Non-English speaking persons","ALL","21 Years",{"count":69,"type":70},231,"ESTIMATED","INTERVENTIONAL",[73],"NA","The purpose of this study is to conduct a randomized trial to evaluate a proactive, opt-out model of provider contact to deliver smoking cessation support for people living with HIV compared to standard care support delivered through traditional clinic pathways. Investigators will also evaluate implementation outcomes to identify barriers and facilitators towards future implementation. Investigators hope to define best practices and optimize the delivery of smoking cessation interventions for people living with HIV.",[76,77],"Hiv","Smoking, Cigarette",[79],"Smoking","2026-01-02",{"date":82,"type":83},"2026-01-06","ACTUAL",{"date":85,"type":83},"2021-12-01",{"date":87,"type":70},"2027-02-28",{"name":5,"class":6},1]